Literature DB >> 9541079

Some reflections on cost-effectiveness analysis.

M Johannesson, D Meltzer.   

Abstract

Mesh：

Year:  1998        PMID： 9541079     DOI： 10.1002/(sici)1099-1050(199802)7:1<1::aid-hec327>3.0.co;2-u

Source DB:  PubMed          Journal:  Health Econ        ISSN： 1057-9230            Impact factor:   3.046


× No keyword cloud information.
  22 in total

1.  Swedish population health-related quality of life results using the EQ-5D.

Authors:  K Burström; M Johannesson; F Diderichsen
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

Review 2.  Theoretical arguments for the discounting of health consequences: where do we go from here?

Authors:  Angelina Lazaro
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  Exploring a new method for deriving the monetary value of a QALY.

Authors:  Carl Tilling; Marieke Krol; Arthur E Attema; Aki Tsuchiya; John Brazier; Job van Exel; Werner Brouwer
Journal:  Eur J Health Econ       Date:  2015-08-20

Review 4.  The relationship between productivity and health-related QOL: an exploration.

Authors:  Werner B F Brouwer; Willem-Jan Meerding; Leida M Lamers; Johan L Severens
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 5.  Willingness to pay for a QALY: theoretical and methodological issues.

Authors:  Dorte Gyrd-Hansen
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 6.  Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?

Authors:  David R Rappange; Pieter H M van Baal; N Job A van Exel; Talitha L Feenstra; Frans F H Rutten; Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

7.  Measuring the end-of-life premium in cancer using individual ex ante willingness to pay.

Authors:  S Olofsson; U-G Gerdtham; L Hultkrantz; U Persson
Journal:  Eur J Health Econ       Date:  2017-08-12

8.  Mitigating hypothetical bias in willingness to pay studies: post-estimation uncertainty and anchoring on irrelevant information.

Authors:  Ana Bobinac
Journal:  Eur J Health Econ       Date:  2018-05-23

9.  Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy.

Authors:  J T Schousboe; D C Bauer; J A Nyman; R L Kane; L J Melton; K E Ensrud
Journal:  Osteoporos Int       Date:  2006-09-20       Impact factor: 4.507

10.  Simultaneous Bilateral Versus Staged Bilateral Carpal Tunnel Release: A Cost-effectiveness Analysis.

Authors:  Kevin W Park; Martin I Boyer; Richard H Gelberman; Ryan P Calfee; Jeffrey G Stepan; Daniel A Osei
Journal:  J Am Acad Orthop Surg       Date:  2016-11       Impact factor: 3.020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.